Stocks have been on a wild ride this week, and conditions could still get weirder as traders brace for “quadruple witching” on Friday, when a flurry of equity options and futures contracts expire. In particular, options contracts tied to $4 trillion in stocks, stock-index futures and exchange-traded funds are set to expire, making Friday potentially … Read more
Elon Musk sold more than $3.5 billion worth of Tesla Inc. stock this week in his second round of sales since buying Twitter Inc. Mr. Musk sold nearly 22 million Tesla shares over a three-day period ending Dec. 14, according to a regulatory disclosure made public Wednesday.
The Federal Reserve’s efforts to tame runaway inflation appear to be working, but there is still a long way to go. Investors rejoiced on Tuesday, sending stocks higher after the release of a fifth-straight monthly consumer-inflation reading that showed diminishing price gains. Expect Fed Chairman Jerome Powell to temper the market’s enthusiasm, however, when he … Read more
The Federal Reserve should declare an immediate cease fire in its war against inflation and hold its benchmark interest rate steady instead of raising the federal funds by a half percentage point to a range of 4.25% to 4.50%, as expected at its meeting that ends Wednesday. With the relatively benign report on the consumer … Read more
To start 2023, investors will have a choice to invest in a brand new $18 billion company with some 50,000 energized employees and a plan to create shareholder value. To close out 2022, that company—GE HealthCare—is on the road, introducing itself to investors. With each new detail that emerges investors get a better sense of … Read more
Oracle shares were moving higher late Monday after the company posted better-than-expected financial results for its latest quarter. The enterprise software giant continued to see success in shifting more of its business to the cloud during the period. “Simply put, we had an outstanding quarter,” Oracle CEO Safra Catz said on a call with analysts. … Read more
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/horizon-therapeutics-coupa-rivian-stock-market-movers-51670601817 Updated Dec. 12, 2022 7:35 am ET / Original Dec. 12, 2022 4:33 am ET Order Reprints Print Article
Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more
“Managers,” Peter Drucker wrote, “must understand that business results depend on a balance of efforts and results in a number of areas.” Yet if the Drucker Institute’s measure of corporate effectiveness is any indication, that is much easier said than done.
Now, a growing crowd is betting on exactly that happening. Mutual funds and hedge funds managing roughly $4.8 trillion in assets have been putting money into stocks that stand to benefit from inflation cooling, interest rates going down and the U.S. economy avoiding a recession, according to an analysis by Goldman Sachs Group Inc. The … Read more